[1]
“Interleukin-13 Inhibitors in the Treatment of Atopic Dermatitis: The Role of Tralokinumab”, Dermatol Pract Concept, vol. 14, no. 3, p. e2024204, Jul. 2024, doi: 10.5826/dpc.1403a204.